Book contents
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Chap. 37 - BOTOX FOR HYPERHIDROSIS
from PART THREE - FILLERS AND NEUROTOXINS
Published online by Cambridge University Press: 06 July 2010
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Summary
AXILLARY HYPERHIDROSIS
The use of BOTOX for the treatment of severe axillary hyperhidrosis was approved by the Food and Drug Administration in 2004 for patients whose hyperhidrosis is inadequately managed with topical agents.
Prior to administering BOTOX, many clinicians perform a Minor's starch iodine test to document the extent and severity of hyperhidrosis in each axilla. This can then be used to mark the skin with a grid of evenly spaced injection sites (Figure 37.1). The approved dose of BOTOX is 50 U per axilla, injected intradermally in 0.1- to 0.2-mL aliquots per injection site using a 30-gauge needle. In the pivotal trials, 100 U were diluted with 4.0 mL of nonpreserved saline. Discomfort with the axillary injections is minimal, and the placing of ice packs on the axillae prior to treatment generally provides sufficient anesthesia. Vibration and topical anesthetic creams have also been successfully employed to reduce pain.
The largest study reported to date was a fifty-two-week, multicenter, double-blind, randomized, placebo-controlled study involving 322 patients with axillary hyperhidrosis (Lowe et al. 2007). The proportion of treatment responders – those achieving a 2-point reduction on the Hyperhidrosis Disease Severity Scale (HDSS) – was significantly greater four weeks after treatment with BOTOX 75 U or BOTOX 50 U than after treatment with placebo (75% and 75% versus 25%; p < 0.001). The median duration of effect of BOTOX treatment was approximately six and a half months.
- Type
- Chapter
- Information
- Office-Based Cosmetic Procedures and Techniques , pp. 163 - 165Publisher: Cambridge University PressPrint publication year: 2010